Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

Completed · Phase 3

Conditions studied: Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor

In brief

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This randomized phase III trial is comparing two different combination chemotherapy regimens to see how well they work in treating patients with stage II or stage III non-seminomatous germ cell tumors.

Key facts

Study ID
NCT00104676
Run by
UNICANCER
People needed
263
Starts
2003-11-26
Expected to finish
2023-02-08
Last updated by the study team
2025-02-06

Who can join

Age: 16 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.